Prognostic significance of oligodendrocyte transcription factor 2 expression in glioma patients: A systematic review and meta-analysis

doi:10.12998/wjcc.v12.i25.5739

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (104)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-6)

Tables (1-2)

Sum=100

Sep 6, 2024 (publication date) through Jul 15, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Clin Cases. Sep 6, 2024; 12(25): 5739-5748
Published online Sep 6, 2024. doi: 10.12998/wjcc.v12.i25.5739

Full Size Figure Download Figure

Figure 3 Forest plot for the association between oligodendrocyte transcription factor 2 expression and overall survival in terms of subgroup analysis of the testing index. HR: Hazard ratio.

Citation: Li PC, Yun DB, Huang YX, Huang QY. Prognostic significance of oligodendrocyte transcription factor 2 expression in glioma patients: A systematic review and meta-analysis. World J Clin Cases 2024; 12(25): 5739-5748
URL: https://www.wjgnet.com/2307-8960/full/v12/i25/5739.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i25.5739